Hongyi Hu

672 total citations
28 papers, 430 citations indexed

About

Hongyi Hu is a scholar working on Molecular Biology, Cancer Research and Otorhinolaryngology. According to data from OpenAlex, Hongyi Hu has authored 28 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Otorhinolaryngology. Recurrent topics in Hongyi Hu's work include Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Hongyi Hu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), MicroRNA in disease regulation (5 papers) and Circular RNAs in diseases (4 papers). Hongyi Hu collaborates with scholars based in China, Hong Kong and United States. Hongyi Hu's co-authors include Jia Liu, Zhen Xie, Weiqiang Yang, Yan Li, Ezra E.W. Cohen, Yaning Wang, Mark Kozloff, Everett E. Vokes, Theodore Karrison and Nicholas W. Choong and has published in prestigious journals such as Oncogene, European Journal of Cancer and BioMed Research International.

In The Last Decade

Hongyi Hu

27 papers receiving 428 citations

Peers

Hongyi Hu
Xun Chen China
Yijun Dong China
Tove Rylander‐Rudqvist Sweden
Hualiang Jin China
Doris Meier-Tackmann Germany
Özlem Demirpençe Türkiye
L. M. Srivastava India
Subrata Debnath United States
Andrey Marusin Russia
Xuejiao Wang China
Xun Chen China
Hongyi Hu
Citations per year, relative to Hongyi Hu Hongyi Hu (= 1×) peers Xun Chen

Countries citing papers authored by Hongyi Hu

Since Specialization
Citations

This map shows the geographic impact of Hongyi Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyi Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyi Hu more than expected).

Fields of papers citing papers by Hongyi Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongyi Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyi Hu. The network helps show where Hongyi Hu may publish in the future.

Co-authorship network of co-authors of Hongyi Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongyi Hu. A scholar is included among the top collaborators of Hongyi Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongyi Hu. Hongyi Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yiwen, et al.. (2025). Role of PD-L1 in mediating the effect of lipid on ulcerative colitis: a mediation Mendelian randomization study. Frontiers in Genetics. 16. 1390605–1390605.
2.
Jiang, Yanyu, et al.. (2024). Ginsenosides: an immunomodulator for the treatment of colorectal cancer. Frontiers in Pharmacology. 15. 1408993–1408993. 6 indexed citations
3.
Zhang, Wen, Gang Wang, Min Cao, et al.. (2022). Clinical predictors and RT-PCR profile of prolonged viral shedding in patients with SARS-CoV-2 Omicron variant in Shanghai: A retrospective observational study. Frontiers in Public Health. 10. 1015811–1015811. 7 indexed citations
4.
Wang, Hanlin, Lu Zhou, Shuaihu Li, et al.. (2022). Dezocine induces apoptosis in human cervical carcinoma Hela cells via the endoplasmic reticulum stress pathway. Toxicology Research. 11(3). 498–510. 2 indexed citations
5.
Yang, Weiqiang, Muhammad Asif, Hafiz Muhammad Jafar Hussain, et al.. (2021). Next-Generation Sequencing Identifies Pathogenic Variants in HGF, POU3F4, TECTA, and MYO7A in Consanguineous Pakistani Deaf Families. Neural Plasticity. 2021. 1–12. 5 indexed citations
6.
7.
Zhou, Yaqi, et al.. (2021). Transcriptomic Analyses Reveal Gene Expression Profiles and Networks in Nasopharyngeal Carcinoma. BioMed Research International. 2021(1). 8890176–8890176. 2 indexed citations
8.
Zhang, Min, Dian Wang, Tian Xiao, et al.. (2020). Therapeutic potential of targeting MKK3-p38 axis with Capsaicin for Nasopharyngeal Carcinoma. Theranostics. 10(17). 7906–7920. 18 indexed citations
9.
Yang, Weiqiang, Yaqi Zhou, Wenbin Lei, et al.. (2020). Risk factors and survival outcomes of laryngeal squamous cell carcinoma patients with lung metastasis: A population-based study. Auris Nasus Larynx. 48(4). 723–730. 2 indexed citations
10.
Yang, Weiqiang, et al.. (2019). Whole‐exome sequencing identifies rare pathogenic and candidate variants in sporadic Chinese Han deaf patients. Clinical Genetics. 97(2). 352–356. 16 indexed citations
11.
Wu, Hanwei, et al.. (2018). Characterization of the Transcriptome of Hair Cell Regeneration in the Neonatal Mouse Utricle. Cellular Physiology and Biochemistry. 51(3). 1437–1447. 2 indexed citations
12.
Li, Yan, Zhen Xie, Yaning Wang, & Hongyi Hu. (2018). Macrophage M1/M2 polarization in patients with pregnancy-induced hypertension. Canadian Journal of Physiology and Pharmacology. 96(9). 922–928. 23 indexed citations
13.
Nie, Guohui, Li Zhao, Liang Luo, et al.. (2017). lncRNA C22orf32-1 contributes to the tumorigenesis of nasopharyngeal carcinoma. Oncology Letters. 13(6). 4487–4492. 15 indexed citations
14.
He, Jie, Wei Xiang, Gang Wan, et al.. (2017). MicroRNA-20a-mediated loss of autophagy contributes to breast tumorigenesis by promoting genomic damage and instability. Oncogene. 36(42). 5874–5884. 57 indexed citations
15.
Hu, Hongyi, et al.. (2017). Dexmedetomidine mitigates CLP-stimulated acute lung injury via restraining the RAGE pathway.. PubMed. 9(12). 5245–5258. 23 indexed citations
16.
17.
Li, Xiaoqing, Hongyi Hu, Yuchi Li, et al.. (2015). Functional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma. Tumor Biology. 36(9). 6679–6689. 24 indexed citations
18.
Lv, Chen, et al.. (2015). Intrathecal SRT1720, a SIRT1 agonist, exerts anti-hyperalgesic and anti-inflammatory effects on chronic constriction injury-induced neuropathic pain in rats.. PubMed. 8(5). 7152–9. 28 indexed citations
19.
Wang, Liang, et al.. (2014). CDK3 expression and its clinical significance in human nasopharyngeal carcinoma. Molecular Medicine Reports. 9(6). 2582–2586. 13 indexed citations
20.
Choong, Nicholas W., Mark Kozloff, David Taber, et al.. (2009). Phase II study of sunitinib malate in head and neck squamous cell carcinoma. Investigational New Drugs. 28(5). 677–683. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xun Chen Breakdown of academic impact, for papers by Yijun Dong Breakdown of academic impact, for papers by Tove Rylander‐Rudqvist Breakdown of academic impact, for papers by Hualiang Jin Breakdown of academic impact, for papers by Doris Meier-Tackmann Breakdown of academic impact, for papers by Özlem Demirpençe Breakdown of academic impact, for papers by L. M. Srivastava Breakdown of academic impact, for papers by Subrata Debnath Breakdown of academic impact, for papers by Andrey Marusin Breakdown of academic impact, for papers by Xuejiao Wang
Rankless by CCL
2026